AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

A research team led by Professor Lee Kun-hee at Gangdong Kyunghee University Hospital has announced new evaluation criteria ...

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

Whether you want passive income or not, dividend-paying stocks tend to outperform their non-dividend-paying cousins.

This may show narrowing of these passageways due to swelling, as well as the presence of nasal discharges. Polyps or septal deviation may be notes and can be a predisposing factor for recurrent sinus ...

Do you find yourself sneezing, itching or battling watery eyes as the seasons change? If so, you may have a pollen ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...